Acob, Abdilla C.

HRN: 27-08-67  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/07/2025
CEFTRIAXONE 1G (VIAL)
05/07/2025
05/14/2025
IV
2G
OD
ASA
Waiting Final Action 
05/07/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
05/07/2025
05/21/2025
IV
500mg
Q8
ASA
Waiting Final Action 
05/11/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
05/11/2025
05/18/2025
IVTT
4.5
Q8
Exlap
Waiting Final Action 
05/14/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
05/11/2025
05/17/2025
IVT
4.5g
Q6
Gut Obstruction With Ruptured Appendicitis With Interloop Abscess
Waiting Final Action 
05/19/2025
CLARITHROMYCIN 500MG (CAP)
05/19/2025
05/25/2025
PO
500mg
BID
Intraabdominal Infection; Pneumonia
Waiting Final Action 
05/20/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
05/20/2025
05/27/2025
IV
4.5
Q6
CAP HR
Waiting Final Action 
05/20/2025
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
05/20/2025
05/27/2025
IV
750
OD
CAP HR
Waiting Final Action 
05/20/2025
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
05/20/2025
05/27/2025
IV
750
OD
CAP HR
Waiting Final Action 
05/20/2025
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
05/20/2025
05/27/2025
IV
750
OD
CAP HR
Waiting Final Action 
05/23/2025
MUPIROCIN 2%, 15G (TUBE)
05/23/2025
05/29/2025
TOPICAL
Pea Size
Q12
Post Appendectomy
Waiting Final Action 
05/25/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
05/25/2025
05/31/2025
IV
525
Q12
Cap-HR
Waiting Final Action 
05/29/2025
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
05/29/2025
06/04/2025
IV
500 Mg
OD
Cap
Remove - Pending Acceptance

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: